Medpal AI plc has acquired the assets of Universal Pharmacy out of administration.
The deal, for a total sum of £45,000, sees it enter the online pharmacy market and triple its robotic warehouse footprint.
Medpal, listed in London and Frankfurt, is an AI-powered healthcare services group which had sought approval from NHS England of its pharmacy licence application – confirming fitness to practice and change of ownership in respect of the NHS pharmacy contract previously held by Universal Pharmacy.
The licence was approved on 4th November 2025 and the pharmacy is now fully operational under Medpal’s ownership.
Consideration for the acquisition comprised an initial payment of £15,000 followed by a final payment of £30,000 on completion.
Universal Pharmacy entered administration in August mired in debt. The assets acquired include leasehold property in the Norfolk town of Swaffham, goodwill and some equipment and stock, as well as Universal’s DSP licence.
The pharmacy premises have been expanded to encompass Units 21, 23, and 25 at Ecotech Innovation Business Park in Swaffham.
SkinBioTherapeutics accuses former CEO of misrepresenting results
This represents a tripling of the facility’s footprint, and creates one of the UK’s most advanced robotic distribution hubs for pharmaceutical services, according to Medpal.
It says the enlarged facility is now structured to operate 24/7 with a capacity to handle over 100,000 prescription items per month with automated dispensing, order fulfilment, and nationwide delivery of prescription and over-the-counter medications.
“We are delighted to have completed this acquisition and facility expansion,” said Jason Drummond (pictured), CEO of Medpal AI.
“The integration of Universal Pharmacy’s operations into our Medpal Limited subsidiary, combined with the tripling of our Swaffham robotic hub, directly supports our vertically integrated model and positions us strongly for accelerated growth.
“This milestone underscores our commitment to building a scalable, technology-driven pharmacy platform that delivers better outcomes for patients, prescribers, and the NHS.”